AI Drug Discovery Health Tech Innovation Atlas (HTIA)
Our Gene Therapy HTIA includes market insights and dynamics, detailed sector and sub-sector descriptions, and companies differentiated by se
top of page
The BHP Blog
Feb 9, 2023
3D Bioprinting Health Tech Innovation Atlas (HTIA)
Our 3D Bioprinting HTIA includes market insights and dynamics, detailed sector and sub-sector descriptions, and companies.
Jan 26, 2023
Brooks Hill Partners Invests in Cellbricks
Brooks Hill Partners has invested in Cellbricks, a 3D bioprinting company transforming pharmaceutical research and clinical care.
Nov 1, 2022
Brooks Hill Partners Joins Raise for Macula Vision Systems
Brooks Hill Partners has joined early-stage financing for Macula Vision Systems, a company focused AI-driven clinical microscopy.
Dec 1, 2020
Brooks Hill Partners Invests in Cake End-of-Life Planning
Brooks Hill Partners has invested in Cake, an end-of-life planning and advanced care decision-making platform.
Nov 1, 2020
Brooks Hill Partners Invests in Totient
Brooks Hill Partners has announced an investment in Totient, an AI-driven biotech company focused on tertiary lymphoid structures.
Dec 1, 2019
Brooks Hill Partners invests in Qulab Seed Financing
Brooks Hill Partners announces an investment in the Seed financing of Qulab, a quantum computing company focused on molecular drug design.
Feb 1, 2018
Brooks Hill Partners Invests in Deep 6 AI
Brooks Hill Partners has invested in Deep 6 AI, a company bringing AI technology to clinical trial recruitment.
Jun 1, 2017
Brooks Hill Partners Joins Round for Reflect
Brooks Hill Partners has announced a new investment in reflect, a teletherapy company providing mental health services built for everyone.
Apr 1, 2017
Brooks Hill Partners Announces Investment in Calibrater Health
Brooks Hill Partners continues to grow their portfolio by investing in Calibrater Health, a company building healthcare workflow automation.
Apr 1, 2017
Brooks Hill Partners Joins Financing for Astrocyte Pharmaceuticals
Brooks Hill Partners has added Astrocyte Pharmaceuticals, a drug development company focused on brain injuries, to their portfolio.
Jan 1, 2017
Brooks Hill Partners Invests in Wasabi
Brooks Hill Partners invests in Wasabi, a startup specializing in high-capacity data archiving cloud services.
Jan 1, 2017
Brooks Hill Partners Announces Investment in 3Derm Systems
Brooks Hill Partners kicks off their healthtech portfolio with an investment in 3Derm Systems, who are focused on 3D imaging in dermatology.
Interested in learning more?
bottom of page